Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
Background Whether guided selection of antiplatelet therapy in patients undergoing
percutaneous coronary intervention (PCI) is effective in improving outcomes compared with …
percutaneous coronary intervention (PCI) is effective in improving outcomes compared with …
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary …
Dual-antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is the standard
treatment for patients undergoing percutaneous coronary intervention. The availability of …
treatment for patients undergoing percutaneous coronary intervention. The availability of …
[引用][C] 2018 ESC/EACTS Guidelines on myocardial revascularization
FJ Neumann, M Sousa-Uva, A Ahlsson… - Russian Journal of …, 2019 - russjcardiol.elpub.ru
acute coronary syndromes, antithrombotic therapy, bare-metal stents, coronary artery
bypass grafting, coronary artery disease, drug-eluting stents, guidelines, heart team …
bypass grafting, coronary artery disease, drug-eluting stents, guidelines, heart team …
[HTML][HTML] Antiplatelet therapy after percutaneous coronary intervention
Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy …
Guidelines, Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dual antiplatelet therapy, Acute
coronary syndromes, Coronary artery bypass grafting, Coronary artery disease, Drug-eluting …
coronary syndromes, Coronary artery bypass grafting, Coronary artery disease, Drug-eluting …
[HTML][HTML] Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19
1 Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute
coronary syndromes in patients presenting without persistent ST-segment elevation. Eur …
coronary syndromes in patients presenting without persistent ST-segment elevation. Eur …
2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing …
The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …
decision pathways, health policy statements, appropriate use criteria) to provide members …
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a …
D Sibbing, D Aradi, C Jacobshagen, L Gross, D Trenk… - The Lancet, 2017 - thelancet.com
Background Current guidelines recommend potent platelet inhibition with prasugrel or
ticagrelor for 12 months after an acute coronary syndrome managed with percutaneous …
ticagrelor for 12 months after an acute coronary syndrome managed with percutaneous …
[PDF][PDF] 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
5. Leczenie.............................................................. 1225 5.1. Farmakoterapia
niedokrwienia...................... 1225 5.1. 1. Ogólne leczenie objawowe................. 1225 5.1. 2 …
niedokrwienia...................... 1225 5.1. 1. Ogólne leczenie objawowe................. 1225 5.1. 2 …
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison
D Capodanno, F Alfonso, GN Levine… - Journal of the American …, 2018 - jacc.org
Dual antiplatelet therapy (DAPT) is the cornerstone of pharmacological treatment aimed at
preventing the atherothrombotic complications in patients with a variety of coronary artery …
preventing the atherothrombotic complications in patients with a variety of coronary artery …